Products
Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Vitamin B12 test kit

NG25

Cat. No.: OB0225WX-1756
Appearance: Solid
Purity: ≥99%
Identity: Confirmed by NMR, HPLC, and LC-MS.
Size:
NG25
Add to basket

Product Overview

Description: NG25 is a dual-targeted kinase inhibitor that suppresses the activities of both TAK1 (IC50: 149 nM) and MAP4K2 (IC50: 21.7 nM).
Synonym: 1315355-93-1; NG-25; N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)benzamide; Benzamide, N-[4-[(4-ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)-; 3-((1H-Pyrrolo[2,3-b]pyridin-4-yl)oxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide; N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methyl-3-(1H-pyrrolo(2,3-b)pyridin-4-yloxy)benzamide; N-[4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)-benzamide; N-{4-[(4-Ethylpiperazin-1-Yl)methyl]-3-(Trifluoromethyl)phenyl}-4-Methyl-3-(1h-Pyrrolo[2,3-B]pyridin-4-Yloxy)benzamide; NG 25; Bis(2,2'-bipyridine)-4,4'-dicarboxybipyridine-ruthenium di(N-succinimidyl ester) bis(hexafluorophosphate) (Technical Grade); N-[4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)benzamide; N-{4-[(4-Ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-4-methyl-3-[(1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]benzamide
CAS No.: 1315355-93-1
Compound CID: 53340664
Formula: C29H30F3N5O2
Formula Weight: 537.58

Specification

Targets&IC50: MAP4K2: 21.7 nM; TAK1: 149 nM
Relative Density: 1.313 g/cm3
Stability: 3 years in powder form.
Storage: Storage at -20°C.
Applications: NG25 is applied in kinase signaling experiments as a dual TAK1 and MAP4K4 inhibitor to investigate the crosstalk between TGF-beta signaling and pro-inflammatory kinase networks.

Library Information

Target: MAPK
Receptor: MAP3K; MAP4K; MAP4K2/TAK1
Pathways: MAPK
Plate Number: AOCL-23
Plate Location: d11
Empty Location: a1-h1; a12-h12
Container: 96-well plate
Formulation: 10mM DMSO
DMSO Max Solubility: 16.67 mg/mL; 31 mM
Inquiry
0
Inquiry Basket
Check Out

Copyright © Protheragen. All rights reserved.